Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer-Reference-Cited by-同舟云学术

Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer

Published:2017-06-29 Issue:12 Volume:109 Page:
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Wyatt Alexander W¹,Annala Matti¹,Aggarwal Rahul¹,Beja Kevin¹,Feng Felix¹,Youngren Jack¹,Foye Adam¹,Lloyd Paul¹,Nykter Matti¹,Beer Tomasz M¹,Alumkal Joshi J¹,Thomas George V¹,Reiter Robert E¹,Rettig Matthew B¹,Evans Christopher P¹,Gao Allen C¹,Chi Kim N¹,Small Eric J¹,Gleave Martin E¹

Affiliation:

1. Affiliations of authors: Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada (AWW, MA, KB, KNC, MEG); Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland (MA, MN); Department of Medicine (RA, FF, JY, AF, PL, EJS) and Department of Radiation Oncology (FF, TMB, JJA, GVT), UCSF Helen Diller Family Comprehe

Funder

NIH

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/109/12/djx118/28244424/djx118.pdf

Reference29 articles.

1. Genomic alterations in cell-free DNA and enzalutamide resistance in castration-resistant prostate cancer;Wyatt;JAMA Oncol,2016

2. Plasma AR and abiraterone-resistant prostate cancer;Romanel;Sci Transl Med,2015

3. Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer;Ulz;Nat Commun,2016